Rankings
▼
Calendar
BIIB FY 2020 Earnings — Biogen Inc. Revenue & Financial Results | Market Cap Arena
BIIB
Biogen Inc.
$28B
FY 2020 Earnings
Healthcare
Drug Manufacturers - General
Income Statement
Revenue
$13.4B
-6.5% YoY
Gross Profit
$11.6B
86.6% margin
Operating Income
$4.6B
34.2% margin
Net Income
$4.0B
29.8% margin
EPS (Diluted)
$24.80
Cash Flow
Operating Cash Flow
$4.2B
Free Cash Flow
$3.8B
Stock-Based Comp.
$198M
Balance Sheet
Total Assets
$24.6B
Total Liabilities
$13.9B
Stockholders' Equity
$10.7B
Cash & Equivalents
$1.3B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$13.4B
$14.4B
-6.5%
Gross Profit
$11.6B
$12.4B
-6.3%
Operating Income
$4.6B
$7.0B
-34.8%
Net Income
$4.0B
$5.9B
-32.1%
← Q4 2019
All Quarters
Q1 2020 →